Filing Details

Accession Number:
0001069530-20-000059
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-21 16:01:33
Reporting Period:
2020-09-18
Accepted Time:
2020-09-21 16:01:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069530 Cassava Sciences Inc SAVA Pharmaceutical Preparations (2834) 911911336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250105 Sanford Robertson One Letterman Drive
Building C - Suite 410
San Francisco CA 94129
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-18 36,281 $8.92 912,623 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.75 to $9.04 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.